Trump's remarks came a day before the Fed was set to announce its next decision on interest rates.Politicsread more
Democratic Rep. Maxine Waters on Tuesday requested that Facebook pause its development of Libra, an upcoming cryptocurrency that the company plans to release in 2020.Technologyread more
"I do expect our stock market to be hammered if nothing positive comes of this G-20 meeting ... the most likely outcome is nothing happens," Jim Cramer says.Mad Money with Jim Cramerread more
The S&P 500 is closing in on its all-time high, and is likely to sail past it, as long as the Fed promises lower interest rates and the trade war calms down.Market Insiderread more
Union Pacific CEO Lance Fritz tells Jim Cramer that he is optimistic about trade relations with China, Mexico, Japan, and the EU.Mad Money with Jim Cramerread more
See which stocks are posting big moves after the bell on June 18.Market Insiderread more
President Donald Trump on Tuesday announced that he will not nominate acting Defense Secretary Patrick Shanahan to hold the position in a permanent capacity. Army Secretary...Politicsread more
But a look at state-by-state data clarifies the scale of Trump's challenge. As the president tries to rally supporters at a 2020 kickoff rally in Orlando on Tuesday, he is...Politicsread more
In a tweet, Trump said that he and Xi "had a very good telephone conversation," and that "our respective teams will begin talks prior to our meeting."Politicsread more
A Bloomberg News report Tuesday morning said the White House had looked at such a move in February.Marketsread more
The order for 200 737 Max jets from British Airways parent IAG was a vote of confidence for Boeing's beleaguered aircraft following two fatal crashes.Airlinesread more
J.P. Morgan Chase CEO Jamie Dimon hosted a private dinner for pharmaceutical executives on Sunday night, ahead of the bank's health-care conference in San Francisco. There was one company not in attendance that received a lot of attention: Amazon.
About 25 industry leaders attended from companies including Eli Lilly, Pfizer and Johnson & Johnson, along with some of the J.P. Morgan's investment bankers, according to two people with knowledge of the event who asked not to be named because it was private.
Dimon gave some details around what he hopes to accomplish through the bank's health partnership, announced last year, with Amazon and Berkshire Hathaway.
He told the room, "We are not happy with health-care costs and want to help," the people said. It's a theme that's gained resonance in Washington, D.C., with President Donald Trump and politicians from both sides of the aisle calling for drugmakers to lower prices.
Dimon was peppered with additional questions about Amazon and its ambitions in the health-care market, after the e-retailer purchased online pharmacy PillPack last year. Amazon also has plans for delivering medical supplies, and the company has reportedly been experimenting in areas like electronic medical records and telemedicine.
Some view Amazon as a potential collaborator, while others see the technology giant as a threat.
The J.P. Morgan-Amazon-Berkshire venture is focused on improving health-care quality while lowering costs, initially for their combined 1.2 million employees. The group has grown to about a half-dozen people from across the health industry, but has not yet revealed its strategy.
"I know last year a lot of your stocks went down after some of my comments," Dimon told the attendees, referencing the partnership with Amazon. He declined to speculate on Amazon CEO Jeff Bezos' plans outside of the group, the people said.
On Tuesday, Eli Lilly CEO Dave Ricks acknowledged the dinner with Dimon while on a panel at the conference, and called for other CEOs to take a more active role in the health benefits for employees. Typically, senior leaders aren't involved in the formation of benefits plans.
"I think here corporate America can lead," Ricks said. "And I'm sure Jamie would welcome that kind of discussion."